Endoscopic resection and ablation versus esophagectomy for high-grade dysplasia and intramucosal adenocarcinoma Jörg Zehetner, MD, Steven R. DeMeester, MD, Jeffrey A. Hagen, MD, Shahin Ayazi, MD, Florian Augustin, MD, John C. Lipham, MD, Tom R. DeMeester, MD The Journal of Thoracic and Cardiovascular Surgery Volume 141, Issue 1, Pages 39-47 (January 2011) DOI: 10.1016/j.jtcvs.2010.08.058 Copyright © 2011 The American Association for Thoracic Surgery Terms and Conditions
Figure 1 A, Flow chart for the 18 patients with intramucosal cancer. B, Flow chart for the 22 patients with high-grade dysplasia. ER, Endoscopic resection; RFA, radiofrequency ablation; IM, intestinal metaplasia; HGD, high-grade dysplasia; IMC, intramucosal cancer. The Journal of Thoracic and Cardiovascular Surgery 2011 141, 39-47DOI: (10.1016/j.jtcvs.2010.08.058) Copyright © 2011 The American Association for Thoracic Surgery Terms and Conditions
Figure 2 Length of Barrett's segment before endoscopic therapy, number of treatment sessions, and pathology at the time of most recent endoscopy and biopsy. IM, intestinal metaplasia. The Journal of Thoracic and Cardiovascular Surgery 2011 141, 39-47DOI: (10.1016/j.jtcvs.2010.08.058) Copyright © 2011 The American Association for Thoracic Surgery Terms and Conditions
Figure 3 Kaplan–Meier curve of overall survival for endoscopic therapy (ET) and esophagectomy (ESO). The Journal of Thoracic and Cardiovascular Surgery 2011 141, 39-47DOI: (10.1016/j.jtcvs.2010.08.058) Copyright © 2011 The American Association for Thoracic Surgery Terms and Conditions